Alan Wright, MD, MPH Chief Executive Officer and Co-Founder, OcularDx, Inc. Alan Wright, MD, MPH, is Chief Executive Officer and Co-Founder of OcularDx, Inc. a precision medicine company developing a vitreous biopsy device and molecular data platform to enable target validation, patient stratification, and companion diagnostics in ophthalmology. Dr. Wright brings over two decades of executive leadership across diagnostics, pharmaceutical, and managed care organizations, including tenures as Chief Medical Officer at bioMérieux North America and Chief Scientific Officer and Chief Medical Officer at Roche Diagnostics. His background spans R&D strategy, regulatory and reimbursement policy, and commercialization for both early-stage ventures and market leaders in the biotech and diagnostics sectors. He holds eight issued U.S. patents related to molecular diagnostics and biomarker-driven care. Dr. Wright serves on the Oversight Committee of the University of Michigan Coulter Translational Medicine Program and the Midwest Biomedical Accelerator Consortium, and previously served on the Coulter Oversight Committee at the University of Missouri. He earned his MD from the University of Pennsylvania School of Medicine and his MPH from the Johns Hopkins School of Hygiene and Public Health.
icon above to turn off Compatibility Mode, which is only for viewing older websites.